FI884626A - Förfarande för framställning av ett terapeutiskt användbart 4H-1-bensopyran-4-onderivat eller dess salt samt en i förfarandet användbar mellanprodukt - Google Patents

Förfarande för framställning av ett terapeutiskt användbart 4H-1-bensopyran-4-onderivat eller dess salt samt en i förfarandet användbar mellanprodukt Download PDF

Info

Publication number
FI884626A
FI884626A FI884626A FI884626A FI884626A FI 884626 A FI884626 A FI 884626A FI 884626 A FI884626 A FI 884626A FI 884626 A FI884626 A FI 884626A FI 884626 A FI884626 A FI 884626A
Authority
FI
Finland
Prior art keywords
useful
benzopyran
salt
derivative
preparation
Prior art date
Application number
FI884626A
Other languages
English (en)
Finnish (fi)
Other versions
FI884626A0 (sv
FI98460C (sv
FI98460B (sv
Inventor
Shuntaro Takano
Chosaku Yoshida
Takihiro Inaba
Keiichi Tanaka
Ryuko Takeno
Hideyoshi Nagaki
Tomoya Shimotori
Shinji Makino
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of FI884626A0 publication Critical patent/FI884626A0/sv
Publication of FI884626A publication Critical patent/FI884626A/sv
Application granted granted Critical
Publication of FI98460B publication Critical patent/FI98460B/sv
Publication of FI98460C publication Critical patent/FI98460C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/54—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 substituted in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
FI884626A 1987-10-08 1988-10-07 Förfarande för framställning av ett terapeutiskt användbart 4H-1-bensopyran-4-onderivat eller dess salt samt en i förfarandet användbar mellanprodukt FI98460C (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP25425187 1987-10-08
JP25425187 1987-10-08
JP11999088 1988-05-17
JP11999088 1988-05-17
JP25081188 1988-10-06
JP63250811A JPH0753725B2 (ja) 1987-10-08 1988-10-06 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤

Publications (4)

Publication Number Publication Date
FI884626A0 FI884626A0 (sv) 1988-10-07
FI884626A true FI884626A (sv) 1989-04-09
FI98460B FI98460B (sv) 1997-03-14
FI98460C FI98460C (sv) 1997-06-25

Family

ID=27313952

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884626A FI98460C (sv) 1987-10-08 1988-10-07 Förfarande för framställning av ett terapeutiskt användbart 4H-1-bensopyran-4-onderivat eller dess salt samt en i förfarandet användbar mellanprodukt

Country Status (16)

Country Link
US (1) US4954518A (sv)
JP (1) JPH0753725B2 (sv)
KR (1) KR910007970B1 (sv)
AT (1) AT397088B (sv)
AU (1) AU605363B2 (sv)
BE (1) BE1002226A5 (sv)
CA (1) CA1320959C (sv)
CH (1) CH679397A5 (sv)
DE (1) DE3834204A1 (sv)
ES (8) ES2013801A6 (sv)
FI (1) FI98460C (sv)
FR (1) FR2621585B1 (sv)
GB (1) GB2210879B (sv)
IT (1) IT1235048B (sv)
NL (1) NL194914C (sv)
SE (1) SE468595B (sv)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
CA2091172C (en) * 1990-09-07 1997-05-20 Adriano Afonso Antiviral compounds and antihypertensive compounds
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5922755A (en) * 1993-04-09 1999-07-13 Toyama Chemical Co., Ltd. Immunomodulator, cell adhesion inhibtor, and agent for treating, and preventing autoimmune diseases
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
ES2324126T3 (es) 1997-11-19 2009-07-30 Kowa Co., Ltd. Derivados de piridazina y medicamentos que los contienen como ingrediente activo.
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
US6649645B1 (en) * 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
JP2001055331A (ja) * 1999-06-11 2001-02-27 Toyama Chem Co Ltd アトピー性皮膚炎治療剤
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
GB0119865D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP3972663B2 (ja) * 2002-01-22 2007-09-05 松下電器産業株式会社 高周波信号受信装置
US7049313B2 (en) * 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
KR101052816B1 (ko) * 2002-04-17 2011-07-29 스미스 클라인 비참 코포레이션 화합물, 조성물 및 방법
CA2485681C (en) 2002-05-24 2012-10-16 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
ATE423110T1 (de) * 2002-07-17 2009-03-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
EP1554265A4 (en) * 2002-09-13 2008-05-07 Cytokinetics Inc COMPOSITIONS, COMPOSITIONS AND M THODES
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7227035B2 (en) * 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US7741519B2 (en) 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
EP2256116A3 (en) * 2002-11-18 2011-11-16 ChemoCentryx, Inc. Aryl sulfonamides
US7420055B2 (en) * 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
DE10256182A1 (de) * 2002-12-02 2004-06-24 Merck Patent Gmbh 2-Oxadiazolchromonderivate
WO2004080991A1 (ja) * 2003-03-14 2004-09-23 Toyama Chemical Co., Ltd. N-[3-(ホルミルアミノ)-4-オキソ-6-フェノキシ-4h-クロメン-7-イル]メタンスルホンアミドの新規な結晶
KR20050113627A (ko) * 2003-03-18 2005-12-02 코와 가부시키가이샤 수용성 페닐피리다진 유도체 및 이를 함유하는 의약
CN100387231C (zh) * 2003-03-24 2008-05-14 天津药物研究院 一种制备古拉替莫固体制剂的工艺及其固体制剂
CN1867566B (zh) * 2003-08-13 2010-06-16 库多斯药物有限公司 氨基吡喃酮和它们作为atm抑制剂的用途
US20050165089A1 (en) * 2003-10-06 2005-07-28 Gustave Bergnes Compounds, compositions and methods
US7402607B2 (en) 2004-09-20 2008-07-22 Kudos Pharmaceuticals Limited DNA-PK inhibitors
TW200638938A (en) * 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR053358A1 (es) * 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
TW200745094A (en) * 2005-08-31 2007-12-16 Kudos Pharm Ltd ATM inhibitor
CN101885717B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
CN101891726B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
CN101885718B (zh) * 2005-10-09 2012-05-23 天津药物研究院 艾拉莫德结晶形态及其组合物
JP4788955B2 (ja) * 2006-01-13 2011-10-05 住友金属工業株式会社 鉄道車両における操舵用アクチュエータの制御方法
AU2006233256B2 (en) * 2006-10-30 2012-01-19 Armaron Bio Pty Ltd Improved flavonols
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
UY31232A1 (es) * 2007-07-19 2009-03-02 Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
JP5828235B2 (ja) 2011-07-21 2015-12-02 新日鐵住金株式会社 鉄道車両用操舵台車
DK2929880T3 (da) * 2013-07-18 2017-01-02 Toyama Chemical Co Ltd Terapeutisk middel til sygdom baseret på hæmmende effekt af makrofag-migrationshæmmende faktor
CN106986797B (zh) * 2017-04-24 2018-09-28 常州佳德医药科技有限公司 N-(2-(4-乙酰苯氧基)-5-甲氧基苯基)甲磺酰胺及其制备方法
CN107021891A (zh) * 2017-04-24 2017-08-08 常州佳德医药科技有限公司 一种艾拉莫德中间体的制备方法
CN111170914B (zh) * 2018-11-09 2021-12-21 成都大学 硒/硫化磺酰芳胺类化合物及其硒/硫化方法
CN109705000A (zh) * 2019-02-26 2019-05-03 南京红杉生物科技有限公司 艾拉莫德中间体及其合成方法
WO2021241725A1 (ja) * 2020-05-29 2021-12-02 富士フイルム富山化学株式会社 高純度のｎ－（５－メトキシ―２－フェノキシフェニル）メタンスルホンアミド及びその製造方法
CN113968836A (zh) * 2020-07-25 2022-01-25 华创合成制药股份有限公司 一种苯并吡喃衍生物及其在类风湿性关节炎治疗中的应用
CN113968838B (zh) * 2020-07-25 2024-04-02 华创合成制药股份有限公司 一种硫代苯并吡喃类化合物及其在类风湿性关节炎治疗中的应用
CN114539104A (zh) * 2022-03-09 2022-05-27 常州佳德医药科技有限公司 一种艾拉莫德中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661990A (en) * 1970-04-13 1972-05-09 Riker Laboratories Inc N-alkylsulfonyl benzoylhaloalkylsulfonanilides
US3689523A (en) * 1971-01-04 1972-09-05 Minnesota Mining & Mfg Substituted haloalkanesulfonanilides
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
GB1499323A (en) * 1974-03-22 1978-02-01 Fisons Ltd 6-substituted chromones and chromanones
DE2537204A1 (de) * 1974-08-23 1976-03-04 Fisons Ltd Neue benzopyrane und verfahren zu ihrer herstellung
EP0009554B1 (de) * 1978-07-27 1983-04-27 Schering Aktiengesellschaft Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE3110009A1 (de) * 1981-03-11 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue benzofuran-derivate, ihre herstellung und verwendung
DE3208079A1 (de) * 1982-03-04 1983-09-08 Schering AG, 1000 Berlin und 4709 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
DE3343331A1 (de) * 1983-11-28 1985-06-05 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von indanyl-derivaten und deren verwendung
US4713393A (en) * 1985-04-25 1987-12-15 Merck & Co., Inc. Phenylpropyl-2,3-dihydrobenzofurans useful as anti-inflammatory agents
PT86407B (pt) * 1986-12-31 1990-11-20 Fujisawa Pharmaceutical Co Processo para a preparacao de novos derivados de alcano-sulfonanilida, e de composicoes farmaceuticas compreendendo os mesmos

Also Published As

Publication number Publication date
SE8803570D0 (sv) 1988-10-07
NL194914B (nl) 2003-03-03
KR890006610A (ko) 1989-06-14
BE1002226A5 (fr) 1990-10-23
FI884626A0 (sv) 1988-10-07
KR910007970B1 (ko) 1991-10-05
NL194914C (nl) 2003-07-04
ES2017836A6 (es) 1991-03-01
ES2017839A6 (es) 1991-03-01
FR2621585B1 (fr) 1994-01-28
DE3834204A1 (de) 1989-04-20
SE468595B (sv) 1993-02-15
CH679397A5 (sv) 1992-02-14
DE3834204C2 (sv) 1992-04-23
ES2017838A6 (es) 1991-03-01
FR2621585A1 (fr) 1989-04-14
IT1235048B (it) 1992-06-17
ES2018111A6 (es) 1991-03-16
GB8823567D0 (en) 1988-11-16
GB2210879B (en) 1991-09-18
FI98460C (sv) 1997-06-25
FI98460B (sv) 1997-03-14
GB2210879A (en) 1989-06-21
ES2017837A6 (es) 1991-03-01
ATA249588A (de) 1993-06-15
NL8802464A (nl) 1989-05-01
AU605363B2 (en) 1991-01-10
IT8848441A0 (it) 1988-10-10
CA1320959C (en) 1993-08-03
ES2013801A6 (es) 1990-06-01
AU2348988A (en) 1989-04-13
SE8803570L (sv) 1989-04-09
ES2018113A6 (es) 1991-03-16
AT397088B (de) 1994-01-25
JPH0249778A (ja) 1990-02-20
JPH0753725B2 (ja) 1995-06-07
US4954518A (en) 1990-09-04
ES2018112A6 (es) 1991-03-16

Similar Documents

Publication Publication Date Title
FI98460B (sv) Förfarande för framställning av ett terapeutiskt användbart 4H-1-bensopyran-4-onderivat eller dess salt samt en i förfarandet användbar mellanprodukt
FI894477A (sv) Förfarande för framställning av terapeutiskt aktiva 7-substituerade 3,5-dihydroxihept-6-ynsyror och deras derivat samt som mellanprodukter användbara föreningar
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
RO84704A (ro) Procedeu pentru prepararea unor derivati de n-piperidinil-benzamide
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
HUT59400A (en) Process for producing thiazole acylamino derivatives substituted with heterocyclic group, as well as pharmaceutical compositions comprising such compounds as active ingredient
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
YU56995A (sh) Soli derivata indola
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
FI884375A (sv) Förfarande för framställning av terapeutiskt användbara N-(1-alkyl-3-hydroxi-4-piperidinyl)bensamider
DE69231663T2 (de) Polysaccharid-protein-konjugate
RU92016595A (ru) Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
PT93450A (pt) Processo para a preparacao de novos derivados azetidinicos de acidos piridinocarboxilicos e de composicoes farmaceuticas que os contem
DK384489A (da) 6-fluor-3,5-dihydroxycarboxylsyrer og deres derivater, deres fremstilling og anvendelser
DE69300453T2 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
SE8801945L (sv) Nya 5-metoxi- aklylammonium- tetrahydrofuraner och -tetrahydrotiofener
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
NO820180L (no) Basisk substituert antranilsyrer, fremgangsmaate til deres fremstilling og deres anvendelse
ES2052133T3 (es) Picolilselenio-benzamidas de aminopiridinas, anilinas y picolilaminas.
RU93058275A (ru) Производные тиофен-2-карбоновой кислоты, способ их получения, фармацевтическая композиция и способ ее получения

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: TOYAMA CHEMICAL CO., LTD.

MA Patent expired